Part 1: Synthesis and characterization of NP for drug delivery1.
Nanoparticles: Recent state-of-art and prospective challenges2.
Fabrication, process technologies and challenges in development of
nanoparticles3. In vitro and physicochemical characterization of
nanoparticles4. Surface-engineering of nanoparticles for imparting
multifuntionality5. Biofate and cellular interactions of
nanoparticles6. Pharmacokinetics and in vivo evaluation of
nanoparticles
Part 2: Application of Nanoparticles in Drug Delivery7.
Biodegradable polymeric nanoparticles for sustained drug delivery8.
Lipidic nanoparticles with improved biopharmaceutical attributes9.
Protein-based nanoparticles for drug delivery10. Gold and silver
nanoparticles for drug delivery11. Mesoporous silica and silicates
nanoparticles for drug delivery12. Targeted nanosuspensions for
improved therapeutics13. SPIONS as therapeutic and diagnostic
agents14. Bio-inspired nanoparticles/exosomes vesicles as drug
delivery vehicles
Part 3: Environmental and Regulatory Aspects14. Regulatory pathways
and federal perspectives on nanoparticles15. Environmental hazards
associated with nanoparticles16. Biological toxicity of
nanoparticles
Dr. Prashant Kesharwani is assistant professor of Pharmaceutics at
Department of Pharmaceutical Sciences, Dr. Harisingh Gour
Vishwavidyalaya, Sagar, Madhya Pradesh, India. He has more than 12
years of teaching, research, and industrial experience at
international levels from various countries, including the United
States, Malaysia, and India. An overarching goal of his current
research is the development of nanoengineered drug delivery systems
for various diseases. He has more than 350 international
publications in well-reputed journals and more than 25
international books (Elsevier). He is a recipient of many research
grants from various funding bodies. He is also the recipient of
several internationally acclaimed awards, such as “USERN Laureate
award, most prestigious “SERB-Ramanujan Fellowship Award. He
actively participates in outreach and scientific dissemination for
the service of the wider community. His Number of citations is =
26779; h-index = 85; i-10 index = 370 (According to google scholar
on March 2025). He has more than 30 international publications
published in very high impact factor journals (Progress in Polymer
Sciences IF 32.063, Molecular Sciences IF 41.444, Progress in
Material Sciences IF 48.580, Advanced Materials IF 29.4, Drug
Resistance Update IF 22.841 and Material Todays IF 32.072). He has
presented many invited talks and oral presentations at prestigious
scientific peer-conferences, received international acclaims and
awards for research contribution, supervised students/junior
researchers and actively participated in outreach and scientific
dissemination for the service of the wider community.
Prof Kamalinder K Singh is Professor of Pharmaceutical Technology &
Drug Delivery and Research Lead at the School of Pharmacy and
Biomedical Sciences, University of Central Lancashire, Preston,
United Kingdom and heads the Nanomedicine and Innovative
technologies research group within the Faculty of Clinical and
Biomedical Sciences and is Healthcare Lead for UCLan Centre of
Smarts Materials. With more than 35 years’ experience in academia,
Prof Singh has contributed significantly to the field of
pharmaceutical technology, drug delivery and nanomedicine through
authorship of over 80 research articles, 18 patents, 12 book
chapters and 60 monographs. Her pioneering research has led to
development of many biocompatible nanoparticle-based platform
technologies exploiting to deliver drugs across various biological
barriers with application to human health and diseases. Prof Singh
serves on International Steering Committee for ‘Handbook of
Pharmaceutical Excipients’, joint publication by AAPS,
Pharmaceutical Press, and Royal Pharmaceutical Society, Great
Britain. She has provided leadership to 35 major funded research
projects and is currently managing several research projects funded
by National Institute of Health, Academy of Medical Sciences,
British Council and UK Foreign Commonwealth and Development Office.
She has supervised 30 ECRs and delivered more than 70 keynotes and
invited talks at prestigious forums around the globe.
"This book is comprehensive, up to date, and well organized and illustrated. It covers all aspects and technologies relevant to nanoparticle therapeutic use and is expected to become a reference in the field of nanotechnology." --DOODY'S BOOK REVIEW SERVICE UPDATE
|
Ask a Question About this Product More... |
|
